MRTX - Mirati Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development58,08568,48748,959
Selling General and Administrative13,45015,29215,755
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-71,535-83,779-64,714
Income from Continuing Operations
Total Other Income/Expenses Net1,105661170
Earnings Before Interest and Taxes-70,430-83,118-64,544
Interest Expense---
Income Before Tax-70,430-83,118-64,544
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-70,430-83,118-64,544
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-70,430-83,118-64,544
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-70,430-83,118-64,544